humanitarian
Translated · Українська · 2–5m lag
Звіт про людські ліки (EPAR): Venabek (попередно Miglustat Gen.Orph), migluстат, Date of Permissionation: 09/ 11/ 2017, vision: 13, status: Authored
Звіт про лікування людських ліків (EPAR): Avolymico, Lslglutide, Date of Pentification: 15/07/2026, revision: 1, Status: Authorized
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewЗвіт про людські ліки (EPAR): Venabek (попередно Miglustat Gen.Orph), migluстат, Date of Permissionation: 09/ 11/ 2017, vision: 13, status: AuthoredEMA What Is NewЗвіт про людські ліки (EPAR): Venabek (попередно Miglustat Gen.Orph), migluстат, Date of Permissionation: 09/ 11/ 2017, vision: 13, status: AuthoredEMA What Is NewHuman medicines European public assessment report (EPAR): Vlustozik (previously Ibuprofen Gen.Orph), ibuprofen, Date of authorisation: 16/02/2024, Revision: 5, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Vlustozik (previously Ibuprofen Gen.Orph), ibuprofen, Date of authorisation: 16/02/2024, Revision: 5, Status: AuthorisedEMA What Is NewЗвіт про людські ліки (EPAR): Bildyos, denosumab, Date of Permissionation: 17/09/2025, revision: 5, Status: AuthorizedEMA What Is NewЗвіт про людські ліки (EPAR): Bildyos, denosumab, Date of Permissionation: 17/09/2025, revision: 5, Status: AuthorizedEMA What Is NewHuman medicines European public assessment report (EPAR): Sycrest, asenapine, Date of authorisation: 01/09/2010, Revision: 23, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Sycrest, asenapine, Date of authorisation: 01/09/2010, Revision: 23, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Rozlytrek, entrectinib, Date of authorisation: 31/07/2020, Revision: 11, Status: AuthorisedEMA What Is NewЗвіт про людські ліки (EPAR): Larglutide STADA, Lirglutide, Date of Pentification: 15/07/2026, consution: 1, Status: AuthorizedEMA What Is NewЗвіт про людські ліки (EPAR): Larglutide STADA, Lirglutide, Date of Pentification: 15/07/2026, consution: 1, Status: Authorized4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources